Intellia Therapeutics: Q1 Earnings Insights

Intellia Therapeutics NTLA reported its Q1 earnings results on Thursday, May 4, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Intellia Therapeutics beat estimated earnings by 16.43%, reporting an EPS of $-1.17 versus an estimate of $-1.4.

Revenue was up $1.35 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 3.16% drop in the share price the next day.

Here's a look at Intellia Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-1.39	-1.28	-1.31	-1.10
EPS Actual	-1.40	-1.49	-1.33	-1.96
Revenue Estimate	11.33M	11.31M	9.42M	8.54M
Revenue Actual	13.57M	13.27M	14.03M	11.25M

To track all earnings releases for Intellia Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.